Management of Heavy Menstrual Bleeding in a Non-Sexually Active 16-Year-Old
For a 16-year-old with heavy menstrual bleeding lasting 10 days per month who is not sexually active, the levonorgestrel-releasing intrauterine device (LNG-IUD) is the most effective first-line treatment option. 1
Initial Assessment
Evaluate for underlying gynecological problems:
- Interactions with medications
- Sexually transmitted infections
- Pregnancy (even if reported as not sexually active)
- Thyroid disorders
- Pathologic uterine conditions (polyps, fibroids)
- Bleeding disorders (especially von Willebrand disease, which has high incidence in adolescents with heavy menstrual bleeding) 2
Check for anemia and assess severity of bleeding
- Heavy menstrual bleeding is clinically defined as ≥80 mL blood loss per cycle 1
- Assess impact on quality of life and daily activities
Treatment Options (In Order of Effectiveness)
1. Levonorgestrel-Releasing IUD (First Choice)
- Most effective option for reducing heavy menstrual bleeding (up to 90% reduction) 1
- Superior to oral medications for treating menorrhagia 1
- Safe and effective in adolescents, including those with bleeding disorders 2
- Provides long-term solution with high continuation rates (≥75% at 1 year) 3
- Benefits:
- Improvement in dysmenorrhea
- No need for daily compliance
- Effective for 3-7 years depending on device
- Can be used in adolescents regardless of sexual activity status
2. Combined Hormonal Contraceptives (Second Choice)
- Effective for reducing menstrual blood loss
- Options include pills, patch, or vaginal ring
- Can be started at any time if reasonably certain patient is not pregnant 3
- Consider extended or continuous regimen to reduce number of periods
- For heavy/prolonged bleeding while using CHCs, consider:
3. Depot Medroxyprogesterone Acetate (DMPA) (Third Choice)
- Injectable option every 13 weeks
- Advantages:
- Improvement in dysmenorrhea
- Protection against iron-deficiency anemia
- No daily compliance needed 3
- For breakthrough bleeding on DMPA:
- NSAIDs for 5-7 days
- Hormonal treatment (low-dose COCs or estrogen) for 10-20 days 3
- Major disadvantages:
- Menstrual irregularities (nearly universal initially)
- Potential weight gain
- Concerns about bone mineral density with long-term use 3
4. Other Medical Therapies
- Tranexamic acid: Reduces menstrual blood loss by 20-60% 4
- NSAIDs: Effective for short-term treatment (5-7 days) during bleeding episodes 3
Treatment Algorithm
Start with LNG-IUD if:
- Bleeding is severe
- Anemia is present
- Patient can tolerate insertion procedure
- Long-term solution is desired
Use Combined Hormonal Contraceptives if:
- Patient declines IUD
- IUD insertion needs to be delayed
- Consider extended cycling (84 active pills/7 placebo) to reduce periods to 4 per year 5
Consider DMPA if:
- Patient declines or has contraindications to above options
- Compliance with daily medication is a concern
- Ensure adequate calcium (1300mg) and vitamin D (600 IU) intake 3
Important Considerations
Bleeding disorders: Screen for bleeding disorders, especially von Willebrand disease, which is common in adolescents with heavy menstrual bleeding 2
Follow-up: Advise patient to return if bleeding persists or worsens despite treatment
Common pitfalls to avoid:
- Assuming heavy bleeding is "normal" in adolescents
- Delaying effective treatment, which can lead to anemia requiring transfusion
- Limiting treatment options based on sexual activity status (LNG-IUD can be used regardless of sexual activity)
- Not screening for underlying bleeding disorders
If bleeding persists despite initial treatment:
- Reevaluate for underlying conditions
- Consider referral to adolescent gynecology or hematology if bleeding disorder is suspected
The LNG-IUD provides the most effective reduction in menstrual blood loss with high satisfaction rates and should be strongly considered as first-line therapy, even in adolescents who are not sexually active 1, 2.